Stock Option and Restricted Stock Compensation for Officers and Employees
First written in FY2017-Q1. 30 of 32 entries say "Advanced", first in FY2017-Q2. Latest entry: 2026-09-29.
- FY2026AdvancedAnnual report
「The total number of issued shares increased as a result of the paid-in issuance of 14,100 new shares as restricted stock-based compensation dated 24 October 2025.」
As equity incentives for officers and employees, the company issued 14,100 restricted shares and also reported an increase of 70,400 shares from the exercise of stock acquisition rights during the fiscal year. - 2026-09-04RestatedGeneral Meetings of Shareholders
「Status of stock acquisition rights granted during the fiscal year under review to executive officers of the company and directors of its subsidiaries as consideration for the performance of their duties」
The year-end status was restated: 114 Series 44 stock acquisition rights, representing 11,400 common shares, were granted to 6 executive officers of the company and 1 director of a subsidiary. - FY2026-H1AdvancedAnnual report
「Eligible recipients and number of people: Company executive officers, 6; directors of subsidiaries, 1. Number of shares underlying the stock acquisition rights: 11,400. Exercise period: from 25 October 2025 to 24 October 2055.」
The 44th Stock Acquisition Rights were issued to 6 company executive officers and 1 subsidiary director, covering 11,400 shares. Under the 45th Stock Acquisition Rights, 7,000 shares were granted to 6 directors, and 14,100 shares were issued to 10 people as specified restricted stock-based compensation. - FY2025AdvancedAnnual report
「The total number of issued shares increased as a result of the paid-in issuance of 14,700 new shares as restricted stock-based compensation dated 25 October 2024.」
The company issued 14,700 restricted shares, and the number of shares also increased by 9,900 through the exercise of stock acquisition rights during the fiscal year. - FY2024AdvancedAnnual report
「At the meeting of the Board of Directors held on 27 September 2024, a resolution was passed to issue the 42nd and 43rd Stock Acquisition Rights as set out below.」
A resolution was passed to additionally issue stock acquisition rights covering 12,000 shares for executive officers and directors of subsidiaries, and 7,200 shares for directors, as equity incentives for officers and employees. - FY2024-Q1AdvancedAnnual report
「359 rights to 37 employees of the company and 1,717 rights to 272 employees of its subsidiaries The company's common shares: 207,600 shares 1 November 2025 to 31 October 2027」
The company granted Series 39 stock acquisition rights to a total of 309 employees of the company and its subsidiaries, covering 207,600 shares, with an exercise period from November 2025 to October 2027. It also issued Series 40 and Series 41 stock acquisition rights and 17,400 restricted shares. - FY2023AdvancedAnnual report
「Series 39 stock acquisition rights: company employees, 38; employees of company subsidiaries, 362; number of shares underlying the stock acquisition rights: 248,800 shares; exercise period: 1 November 2025 to 31 October 2027」
Regarding share-based incentives for officers and employees, the company resolved to issue an additional 248,800 shares' worth of stock acquisition rights for 400 employees. It also resolved to issue Series 40 and Series 41 stock acquisition rights for directors and executive officers. - FY2023-Q2AdvancedAnnual report
「Board of Directors resolution dated 28 September 2022 (Series 38 stock acquisition rights) Categories and number of eligible persons (people) Company employees: 38; employees of company subsidiaries: 299 Number of shares underlying the stock acquisition rights (shares) 140,700 Exercise period for the stock acquisition rights 1 November 2024 to 31 October 2026」
Regarding share-based incentives for officers and employees, the company issued Series 36, Series 37 and Series 38 stock acquisition rights, granting employees and others rights covering a total of 140,700 shares. It also reported the issuance of 16,800 specific restricted shares and an increase of 38,100 shares through the exercise of stock acquisition rights. - FY2023-Q1AdvancedAnnual report
「221 rights to 38 employees of the company and 1,186 rights to 299 employees of its subsidiaries (2) Class and number of shares underlying the stock acquisition rights The company's common shares: 140,700 shares (6) Exercise period for the stock acquisition rights 1 November 2024 to 31 October 2026」
The company granted Series 38 stock acquisition rights to a total of 327 employees of the company and its subsidiaries, covering 140,700 shares, with an exercise period from November 2024 to October 2026. It also issued stock acquisition rights and restricted shares to directors, executive officers and others. - FY2022-Q3AdvancedAnnual report
「Categories and number of eligible persons (people) Company employees: 40; employees of company subsidiaries: 287 Number of stock acquisition rights (rights) 1,098 Number of shares underlying the stock acquisition rights (shares) (Note 1) 109,800 Exercise period for the stock acquisition rights From 1 April 2024 To 31 March 2026」
The company granted Series 35 stock acquisition rights to 327 employees of the company and its subsidiaries, covering 109,800 shares, with an exercise period from April 2024 to March 2026. - FY2022-Q2AdvancedAnnual report
「Increase in total number of issued shares: 37,100 shares (Note 2: Increase through the exercise of stock acquisition rights)」
During the second quarter, 37,100 shares were added through the exercise of stock acquisition rights. On 27 October 2021, the company also issued 17,300 restricted shares to 13 directors, executive officers and subsidiary directors. - FY2022-Q1AdvancedAnnual report
「Based on a resolution of the Board of Directors dated 28 September 2021, the company issued the securities described below on 27 October 2021.」
The company granted Series 33 and Series 34 stock acquisition rights to directors, Audit & Supervisory Committee members, executive officers and subsidiary directors, issuing share-based compensation covering a total of 22,300 shares. It also issued 17,300 restricted shares. - FY2021AdvancedAnnual report
「The increase of 282,900 issued common shares resulted from the issuance of 15,500 restricted shares on 23 October 2020 pursuant to a resolution of the Board of Directors dated 25 September 2020, and the exercise of stock options covering 267,400 shares.」
The company issued 15,500 restricted shares and exercised stock acquisition rights covering 267,400 shares, further implementing share-based incentives for officers and employees. - FY2021-Q3AdvancedAnnual report
「Between 1 April 2021 and 30 April 2021, the total number of issued shares increased by 2,500 through the exercise of stock acquisition rights.」
During the third quarter, 4,600 shares were added through the exercise of stock acquisition rights, and a further 2,500 shares were issued in April 2021 before the filing date. - FY2021-Q2AdvancedAnnual report
「1 October 2020 to 31 December 2020」
During the second quarter, the total number of issued shares increased by 71,500 through the exercise of stock acquisition rights, marking further implementation of share-based incentives for officers and employees. - FY2021-Q1AdvancedAnnual report
「187 rights to 43 employees of the company and 991 rights to 320 employees of its subsidiaries」
The company issued Series 30 stock acquisition rights for employees, Series 31 and Series 32 stock acquisition rights for directors and Audit & Supervisory Committee members, and 15,500 restricted shares, further implementing share-based compensation. - FY2020-Q2AdvancedAnnual report
「Categories and number of eligible persons (people) Company employees: 235; employees of company subsidiaries: 99」
The company issued Series 27 through Series 29 stock acquisition rights to employees, directors and corporate auditors of the company and its subsidiaries, adding share-based incentives covering a total of 106,300 shares. It also issued 15,800 restricted shares to 13 directors and subsidiary directors. - FY2020-Q1AdvancedAnnual report
「Based on a resolution of the Board of Directors dated 27 September 2019, the company issued the securities described below on 25 October 2019.」
The company issued Series 27 through Series 29 stock acquisition rights, adding share-based incentives covering a total of 106,300 shares for employees of the company and its subsidiaries, directors and corporate auditors. It also issued 15,800 restricted shares. - FY2019AdvancedAnnual report
「The increase resulted from the issuance of 23,300 restricted shares on 25 October 2018 and the exercise of stock options covering 133,200 shares.」
The issuance of 23,300 restricted shares and the exercise of stock options covering 133,200 shares were recorded, marking further implementation of share-based incentives for officers and employees. - FY2019-Q3AdvancedAnnual report
「Between 1 April 2019 and 30 April 2019, the number of issued shares increased by 1,800 through the exercise of stock acquisition rights.」
During the third quarter, a further 5,800 shares were added through the exercise of stock acquisition rights, and 1,800 additional shares were issued in April before the filing date. - FY2019-Q2AdvancedAnnual report
「Board of Directors resolution dated 26 September 2018 (Series 24 stock acquisition rights) Categories and number of eligible persons (people) Company employees: 232; employees of company subsidiaries: 99 Number of shares underlying the stock acquisition rights (shares) (Note 1) 162,500 Exercise period for the stock acquisition rights From 1 November 2020 To 31 October 2022」
The company granted Series 24 stock acquisition rights to employees of the company and its subsidiaries, covering 162,500 shares, with an exercise period from 1 November 2020 to 31 October 2022. - FY2019-Q1AdvancedAnnual report
「1,354 rights to 232 employees of the company and 271 rights to 99 employees of its subsidiaries」
The company allocated Series 24 stock acquisition rights to employees of the company and its subsidiaries, covering a total of 162,500 shares, with an exercise period from 1 November 2020 to 31 October 2022. It also issued additional stock acquisition rights and restricted shares to directors, corporate auditors and subsidiary officers. - FY2018-Q3AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the third quarter, 9,800 shares were added through the exercise of stock acquisition rights, marking further implementation of share-based incentives for officers and employees. - FY2018-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
The company issued stock acquisition rights Nos. 21 through 23, granting officers and employees rights covering a total of 165,000 shares. It also issued 24,500 restricted shares to 13 directors and subsidiary directors, and recorded an increase of 10,200 shares through the exercise of stock acquisition rights. - FY2018-Q1AdvancedAnnual report
「Based on a resolution of the Board of Directors dated 27 September 2017, the company issued the securities described below on 26 October 2017.」
After the filing, the company issued 24,500 restricted shares and stock acquisition rights to its directors and subsidiary directors, marking further implementation of a share-based incentive plan. - FY2017AdvancedAnnual report
「The increase of 5,320,500 issued common shares resulted from an increase of 5,112,900 shares through a 2-for-1 stock split effective 1 October 2016, an increase of 35,700 shares from restricted stock issued on 2 November 2016 pursuant to a resolution of the Board of Directors held on 7 October 2016, and 171,900 shares issued through the exercise of stock options.」
In addition to the issuance of 35,700 restricted shares, 171,900 shares were added through the exercise of stock options during the fiscal year, marking further implementation of share-based incentives. - FY2017-Q3AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights. Between 1 April 2017 and 30 April 2017, the total number of issued shares increased by 11,000 through the exercise of stock acquisition rights, while share capital and capital reserves each increased by ¥2,277 thousand.」
During the third quarter, 42,600 shares were added through the exercise of stock acquisition rights, and a further 11,000 shares were issued in April before the filing date, marking further implementation of share-based incentives for officers and employees. - FY2017-Q2AdvancedAnnual report
「Paid issuance of new shares as specific restricted stock compensation」
On 2 November 2016, the company issued 35,700 shares to a total of 11 directors and subsidiary directors. During the cumulative second quarter, 85,400 shares were also added through the exercise of stock acquisition rights, marking further implementation of share-based incentives for officers and employees. - FY2017-Q1First statedAnnual report
「The company issued stock acquisition rights covering 294,200 of its common shares, with 1,271 rights granted to 242 employees of the company and 200 rights granted to 92 employees of its subsidiaries.」
In addition to stock acquisition rights for employees, directors and corporate auditors, the company issued 35,700 restricted shares to its directors and subsidiary directors and introduced a share-based incentive plan.